Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and

H K Hammond1, D A Roth, P A Insel

  • 1VAMC San Diego, CA 92161.

Circulation
|January 1, 1992
PubMed

Insights

Volume overload from aortocaval fistula causes circulatory congestion and decreases beta-adrenergic receptor (beta AR) signaling in the heart. This desensitization occurs without contractile dysfunction, indicating neurohumoral tone

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Adrenergic Signaling

Background:

  • Aortocaval fistula induces a unique volume-overload state without significant contractile dysfunction.
  • This model allows direct assessment of neurohumoral adrenergic tone's influence on beta-adrenergic receptor (beta AR) signaling.
  • Understanding this pathway clarifies peripheral versus primary myocardial factors in signal transduction abnormalities.

Purpose of the Study:

  • To investigate the beta-adrenergic receptor-responsive adenylyl cyclase pathway in volume-overload hypertrophy with circulatory congestion.
  • To determine if neurohumoral factors alone can induce beta AR pathway desensitization.
  • To differentiate the roles of contractile function versus adrenergic tone in myocardial signaling.

Main Methods:

  • Hemodynamic and pharmacological studies in pigs before and after aortocaval fistula placement.
  • Biochemical analysis of plasma and cardiac tissue (right atrium, right ventricle, left ventricle).
  • Measurement of beta-adrenergic receptor number, agonist binding affinity, adenylyl cyclase activity, and Gs protein levels.

Main Results:

  • Circulatory congestion signs (tachypnea, weight gain, ascites) developed within 3-4 weeks.
  • Heart rate responsiveness to beta AR stimulation was blunted.
  • Significant decreases in beta AR number (36-41%) and adenylyl cyclase activity (44-50%) were observed in cardiac ventricles and atria.
  • Downregulation was selective for beta 1-receptors, with evidence of uncoupling from Gs.
  • Cardiac Gs protein levels were decreased in volume-overloaded animals.

Conclusions:

  • Biochemical changes occurred without myocardial inflammation or fibrosis, suggesting circulatory congestion is a sufficient stimulus.
  • Elevated plasma norepinephrine likely drives beta AR pathway desensitization.
  • Abnormalities in the myocardial beta AR-responsive adenylyl cyclase pathway do not require a primary defect in intrinsic contractile function.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...